Get unlimited access to ad-free articles and exclusive content. MyHealthNewsDaily Testosterone therapy, in which testosterone is administered to men with low levels of the hormone, has been a ...
The safety evidence from TRAVERSE refers to men with confirmed low testosterone levels — below 300 nanograms per decilitre of ...
AbbVie announced that the FDA has approved a new packaging option for AndroGel (testosterone gel) 1.62%. Besides the previously approved metered-dose pump packaging, Androgel 1.62% will also be ...
Dosage and administration for AndroGel 1.62% differs from AndroGel 1% and the two are not interchangeable. At the starting dose, AndroGel 1.62% contains 40.5mg of testosterone in two pump presses, ...
Testosterone could be the secret ingredient in turning a profit on the stock market, British researchers say. The researchers have found financial traders make more money when their testosterone ...
The FDA has approved Abbott’s AndroGel 1.62%, a testosterone gel that restores levels of the hormone in hypogonadal men with half the volume of gel at the starting dose than delivered in AndroGel 1%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results